A joint venture has sold a majority interest in a Parsippany office building, following upgrades at the property that helped lure a pharmaceutical company’s U.S. headquarters in 2018.
Teva Pharmaceuticals isn’t the only life sciences company to impact New Jersey’s office market this year, as several others have inked sizable leases to expand or upgrade their space.
